Author
  Prof. Klaus Mann is head of the Department of Endocrinology at the University of Essen. He and his coworkers Prof. Dr. Rudolf Hörmann and Dr. Bernhard Saller have a long-lasting clinical and scientific interest in the field of thyroid diseases. As the representative of the Thyroid Section of the German Endocrine Society he presently is responsible for preparation and distribution of national guidelines for diagnosis and treatment of thyroid diseases. main areas of work have been thyroid autoimmunity, iodine deficiency and excess and hyperthyroidism in pregnancy and trophoblastic tumors. As a model for specific pharmacological interaction with the TSH receptor an hCG derived experimental TSH receptor antagonist was developed. Clinical and molecular experience extends to a variety of rare diseases such as multiple endocrine neoplasia, thyroid hormone resistance and TSH producing tumors.